Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04294563 · ClinicalTrials.gov registry record · NA
Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty
A NA study, sponsored by Auburn University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04294563: Clinical Trial NA study, sponsored by Auburn University.
NCT04294563 is a NA study that was terminated before completion, run by Auburn University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04294563, a NA study, was terminated before completion, sponsored by Auburn University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This randomized controlled trial will study the effects of peanut protein supplementation on changes in muscle size and quality in patients undergoing total knee arthroplasty.
Primary Outcome
peripheral quantitative computed tomography (pQCT) cross-sectional image of mid-right thigh assessed for total muscle cross-sectional area
Interventions
- DIETARY_SUPPLEMENT Peanut Protein Powder
- OTHER Standard Care by Surgeon and Physical Therapist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Why NCT04294563 stopped before completion
NCT04294563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Peanut Protein Powder is the first listed.
NCT04294563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04294563 about?
NCT04294563 is a clinical study titled "Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty". This randomized controlled trial will study the effects of peanut protein supplementation on changes in muscle size and quality in patients undergoing total knee arthroplasty.
What is the current status of trial NCT04294563?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-08-01. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04294563?
The interventions under investigation include: Peanut Protein Powder (DIETARY_SUPPLEMENT), Standard Care by Surgeon and Physical Therapist (OTHER).
Who is sponsoring clinical trial NCT04294563?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04294563's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI